Development pipeline
Progress measured by evidence.
Applied Regenerative Therapeutics communicates each technology at its current stage and advances only when the evidence supports the next development decision.
Current portfolio
Five technologies. Three scientific platforms. One translational discipline.
TechnologyCurrent stageNext milestonePosition
01Veredis™ Osteoinductive MatrixCharacterization + in vitro testingComplete biological assays; initiate small-animal proof of conceptLead technology
02Veredis™ Matrix Reconditioning ProcessDevelopment-stageContinue characterization within a protected development pathPlatform technology
03Veredis™ Conductive MatrixConcept developmentDefine material architecture and initial feasibility workNear-term development
04Rasalis™ Regenerative ResetEarly in vitro proof of conceptConfirm reproducibility and expand biological validationDiscovery
05Fusanix™ Osteoinductive PlatformEarly discovery + in vitro activityAdvance variant characterization and intellectual-property strategyDiscovery
Near-term focus
Advance the Veredis™ osteoinductive matrix from in vitro characterization toward in vivo proof of concept.
Analytical characterizationIn vitro biological performanceSmall-animal feasibilityPartner-aligned development
Partner with Applied Regenerative Therapeutics
Bring complementary capabilities to the pipeline.
Applied Regenerative Therapeutics is interested in strategic relationships with tissue processors, orthobiologic companies, research groups, and investors.
Explore Partnership Opportunities